Kedrion Biopharma and InstaLILY to Host Healthcare AI Innovation Summit at NY Tech Week
Kedrion Biopharma and InstaLILY will co-host the Rare Connections: Healthcare AI Innovation Summit on June 3 as part of NY Tech Week, announced in a press release. The invitation-only event will gather leaders from the pharmaceutical, technology, investment, and research sectors to explore how organizations are implementing artificial intelligence across healthcare.
The half-day summit will include sessions on clinical development, commercial operations, specialty pharmacies, investment strategy, and responsible technology adoption. Discussions will focus on how AI is being used to improve decision making, patient access, and healthcare outcomes.
Speakers will include representatives from Google DeepMind, Bain Capital Private Equity, Kedrion Biopharma, InstaLILY AI, Insight Partners, and other organizations. The event aims to highlight practical examples of AI adoption that enhance operational efficiency and patient experiences.
The summit will take place on June 3 in New York during NY Tech Week. Interested participants can request to join the waitlist through the event website.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Veeva to Showcase Falcon and Vault AI at Boston Summit
Kipu Health Plans ELEVATE 2027 AI Preview for May
Sequential Plans London Conference on AI Ingredient Discovery
Xtalks Plans Webinar on AI Governance in Clinical Development
Linearis Joins Two Canadian AI Health Data Projects
Daily AI Brief: the AI news that matters, in your inbox.